Filter
2537
Filtered Results: 2537
Text search:
Global
TB
Programme
Featured
Recommendations
209
New Publications
690
Language
Document type
No document type
1606
Studies & Reports
401
Guidelines
261
Strategic & Response Plan
96
Manuals
90
Fact sheets
30
Training Material
23
Situation Updates
16
Infographics
8
Resource Platforms
5
Brochures
1
Countries / Regions
India
107
Global
97
South Africa
84
Kenya
82
Western and Central Europe
71
Zambia
59
Malawi
51
Nepal
50
Tanzania
49
Uganda
49
Sierra Leone
47
Africa
47
Namibia
46
Nigeria
45
Eastern Europe
44
Ghana
42
Myanmar / Burma
42
Ethiopia
41
Lesotho
35
Bangladesh
33
Senegal
31
Liberia
29
Asia
28
Ukraine
27
Rwanda
25
South–East Asia Region
25
Congo, Democratic Republic of
24
Zimbabwe
22
Cambodia
18
Latin America and the Carribbean
17
Burkina Faso
14
Benin
13
Mozambique
13
South Sudan
13
Indonesia
13
Haiti
12
East and Southern Africa
12
Russia
12
Cameroon
11
Pakistan
11
Central African Republic
10
Botswana
10
Syria
9
Philippines
9
Madagascar
9
Colombia
8
Guinea
8
Albania
7
Tajikistan
6
Armenia
6
West and Central Africa
6
Middle East and North Africa
6
Georgia
6
Eswatini/ Swaziland
6
Sudan
5
Yemen
5
Afghanistan
4
Burundi
4
Venezuela
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
Bolivia
4
Brazil
4
Laos
3
Peru
3
Jordan
3
Germany
3
Southern Africa
3
Argentina
3
Lebanon
3
Moldova
3
Sri Lanka
3
Somalia
3
North Macedonia
2
Timor Leste/ East Timor
2
Thailand
2
El Salvador
2
Iran
2
Niger
2
Morocco
2
Saudi Arabia
2
Vietnam
2
Angola
2
Bhutan
2
Iraq
2
North Korea
1
Mexico
1
Turkey
1
Gambia
1
Togo
1
Qatar
1
Bulgaria
1
Guinea-Bissau
1
Ireland
1
Paraguay
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Tunisia
1
Spain
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Djibouti
1
Egypt
1
Romania
1
Greece
1
Palestine
1
Honduras
1
Mali
1
Chad
1
Libya
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1077
Clinical Guidelines
174
Public Health
110
Key Resources
67
Women & Child Health
65
Pharmacy & Technologies
31
Capacity Building
29
Toolboxes
TB
507
HIV
409
AMR
94
COVID-19
81
NTDs
57
Mental Health
52
Health Financing Toolbox
48
Caregiver
47
Global Health Education
45
Disability
38
NCDs
34
Refugee
28
Ebola & Marburg
27
Conflict
27
Planetary Health
23
Pharmacy
23
Polio
16
Rapid Response
15
Malaria
14
Natural Hazards
13
2.0 Rapid Response
9
Social Ethics
4
Zika
4
Specific Hazards
2
South Sudan
1
Cholera
1
This two-page summary provides a problem analysis of the U.S. cuts in global health and derives concrete recommendations for action for medical actors. The focus is on analyzing the direct effects on health-specific development cooperation.
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people and kills more than 1.4 million people. WHO’s Digital Health for the End TB Strategy – an Agenda for Action o...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Framework for implementation.
The END TB Strategy.
Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management
recommended
The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The gu...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...
La lutte contre la tuberculose est une des priorités du ministère de la santé. C’est ainsi que le Plan Stratégique National de lutte contre la Tuberculose 2013-2017 du Sénégal a inscrit dans son programme d’actions la préoccupation de mieux d’améliorer la prise en charge des personnes ...
Migration Health Division Information Sheet Series
Migration Health Assistance for Crisis-Affected Populations
HIV/AIDS, TB, Malaria, Cholera, Re/Emerging Diseases and Mobility
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘...
This rapid communication outlines the main outcomes of a WHO convened Guideline Development Group (GDG) meeting, held in May-June 2021 on the topic of the management of TB in children and adolescents. The rapid communication aims to inform staff from ministries of health and care providers across p...
Improving the management of childhood tuberculosis within national tuberculosis programmes: research priorities based on a literature review
WHO/HTM/TB/2007.381, 07.02
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
Int J Tuberc Lung Dis. 2019 Jul 1;23(7):858–864.Namibia ranks among the 30 high TB burden countries worldwide. Here, we report results of the second nationwide anti-TB drug resistance survey. To assess the prevalence and trends of multidrug-resistant TB (MDR-TB) in Namibia.
From 2014 to 2015, pat...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
